PHASERX WEBSITE
PHASERX WEBSITE
Our breakthrough nanotechnology holds new promise for challenging diseases
PhaseRx is developing RNA nanomedicines for the treatment of orphan diseases. The Company’s innovative approach to drug discovery and development is based on its proprietary SMARTT Polymer Technology®, which offers effective mRNA delivery, a favorable side effect profile and robust and scalable manufacture.
© 2014 PhaseRx, Inc.     410 West Harrison Street, Suite 300, Seattle WA 98119     206.805.6300 Terms of Use Site Design